Press Release (ePRNews.com) - BRISTOL, England - Nov 01, 2016 - From its inception just a decade ago, the Zepto capsulotomy device has come a long way. CEO John Hendrick tells us the Mynosys story, which shows how a small start-up can shake up the medical field by tackling one of the most challenging and crucial steps in cataract surgery.
Cataracts develop when the lens of the eye gradually becomes less transparent, preventing light from entering the eye, and thereby affecting sight. They are often associated with age, and eventually require surgery to treat. According to the NHS, cataracts are the number one cause of impaired vision globally, and most people aged over 65 in the UK have some kind of visual impairment as a result of cataracts. Fittingly, therefore, cataract surgery is the most commonly performed surgery in the USA and EU. Thus, the potential impact of improved technology for cataract surgery is huge, says CEO John Hendrick at Mynosys, who have developed a new ‘Zepto’ device for the job.
http://researchfeatures.com/2016/10/31/revolution-cataract-surgery/ Source :